Objective Evidence That Supports CBD for Insomnia

Interview by Alyx Arnett Cannabidiol, or CBD for short—the non-intoxicating compound derived from the cannabis plant—has gained significant attention over the last several years for its potential therapeutic properties, including improving sleep, but little scientific evidence has existed to support such benefits.  Paul J. Muchowski, PhD A recent clinical trial has shed new light on…

Read More

Physician Discovers Surprising Possible Side Effect of Xywav in Narcolepsy Patient

By Jeffrey McGovern, MD, FAASM, FCCP “Frame your mind to mirth and merriment, which bars a thousand harms and lengthen life”—William Shakespeare (The Taming of the Shrew, Scene 2 introduction) Narcolepsy is a disorder primarily characterized by excessive daytime sleepiness and signs of rapid eye movement (REM)-sleep dissociation manifested in type 1 pattern as cataplexy…

Read More

Nox Health Closes Acquisition of Somryst

Nox Health has closed the acquisition of Somryst, the only US Food and Drug Administration-approved prescription digital therapeutic that delivers first-line treatment for adults with chronic insomnia, from Pear Therapeutics.  The addition of Somryst expands Nox Health’s suite of tools and programs that address a critical and growing demand for sleep care management for populations…

Read More